fine-tun pro forma model aet re-
segment line item
updat pro forma estim meaning chang oper
forecast adjust cvs/aet pro forma ep
respect reflect latest
quarterli upsid slightli higher blend tax rate higher non-
control interest expens relat aetna importantli made
monument chang pro forma oper forecast
stand-alone adjust despit initi guidanc would
includ aetna deal-rel debt stand-alone result announc
fact exclud associ interest expens consequ
rais stand-alone ep primarili
lower interest expens note deal-rel debt
still reflect pro forma assumpt diagnos
reiter outperform continu view cvs/aet deal
conceptu appeal highlight respect oper perform
aet note manag aj rice
strong start disclos updat pend
deal howev regulatori process progress accord plan
broadli view deal logic next step evolv hc servic
continuum rfp flow temper pbm custom await clariti
industri consolid note call recent propos hh
lack hard-hit plan left consider room industri feedback
contribut relief suppli chain share moreov
emphas expect propos polici neg impact
profit overal rebat commentari rel better fear
potu speech lack punch next await commentari
competitor walgreen boot allianc outperform sell-sid
valuat metric
number share
price month
 close
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
caremark corpor caremark pharmaci
healthcar provid unit state provid pharmaci
servic pharmaci benefit manag pbm mail
order specialti pharmaci divis caremark pharmaci
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
cash-flow financ activ
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
better fundament perform sentiment could drive upsid
target price blue sky scenario
weaker fundament perform sentiment could lead
downsid versu target price grey sky scenario
 close
compani mention price
